EMCLL-06 Cell Line
To Order Contact us: bjorn@lembcke.dk
293LTV Cell Line |
|||
| LTV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293LTV Cell Line is derived from the parental 293 cells but selected for attributes that increase lentiviral production, including fimrer attachment and larger surface area. |
|||
293AD Cell Line |
|||
| AD-100 | Cell Biolabs | 1 vial | EUR 461 |
|
Description: The 293AD Cell Line is derived from the parental 293 cells but selected for attributes that increase adenovirus production, including firmer attachment and larger surface area. |
|||
293AAV Cell Line |
|||
| AAV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293AAV Cell Line is derived from the parental 293 cells but selected for attributes that increase AAV production, including firmer attachment and larger surface area. |
|||
293RTV Cell Line |
|||
| RV-100 | Cell Biolabs | 1 vial | EUR 508 |
|
Description: The 293RTV Cell Line is derived from the parental 293 cells but selected for attributes that increase retroviral production, including fimrer attachment and larger surface area. |
|||
293/GFP Cell Line |
|||
| AKR-200 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: 293/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
T47D/GFP Cell Line |
|||
| AKR-208 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: T47D/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
A549/GFP Cell Line |
|||
| AKR-209 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: A549/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
HeLa/GFP Cell Line |
|||
| AKR-213 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: HeLa/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
NIH3T3/GFP Cell Line |
|||
| AKR-214 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: NIH3T3/GFP Cell Line stably expresses GFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
NIH3T3/Cas9 Cell Line |
|||
| AKR-5104 | Cell Biolabs | 1 vial | EUR 572 |
293/Cas9 Cell Line |
|||
| AKR-5110 | Cell Biolabs | 1 vial | EUR 572 |
HeLa/Cas9 Cell Line |
|||
| AKR-5111 | Cell Biolabs | 1 vial | EUR 572 |
YKL-06-061 |
|||
| HY-120056 | MedChemExpress | 10mM/1mL | EUR 157 |
JH-RE-06 |
|||
| HY-126214 | MedChemExpress | 1mg | EUR 452 |
55486-06-1 |
|||
| TBZ0280 | ChemNorm | 5mg | Ask for price |
109237-06-1 |
|||
| TBZ0433 | ChemNorm | unit | Ask for price |
SKOV-3/Luc Cell Line |
|||
| AKR-232 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: SKOV-3/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
MCF-7/Luc Cell Line |
|||
| AKR-234 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: MCF-7/Luc Cell Line stably expresses luciferase and otherwise exhibits the same characteristics of the parental cell line. |
|||
OVCAR-5/RFP Cell Line |
|||
| AKR-254 | Cell Biolabs | 1 vial | EUR 572 |
|
Description: OVCAR-5/RFP Cell Line stably expresses RFP and otherwise exhibits the same characteristics of the parental cell line. |
|||
Platinum-E Retroviral Packaging Cell Line, Ecotropic |
|||
| RV-101 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-E cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Platinum-A Retroviral Packaging Cell Line, Amphotropic |
|||
| RV-102 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-A cells contain gag, pol and env genes, allowing retroviral packaging with a single plasmid transfection. |
|||
Platinum-GP Retroviral Packaging Cell Line, Pantropic |
|||
| RV-103 | Cell Biolabs | 1 vial | EUR 920 |
|
Description: Conventional cells used for retrovirus packaging, such as those based on NIH3T3 cells, have limited stability and produce relatively low yields of retrovirus, mainly due to the poor expression of retroviral structure proteins (gag, pol and env) in the cells. The Platinum Retroviral Packaging Cell Lines are based on the 293T cell line. They exhibit longer stability and produce higher yields of retroviral structure proteins. Plat-GP cells contain the gag and pol genes required for retroviral packaging; an expression vector is co-transfected with a VSVG envelope vector. |
|||
Monoclonal TUBB / Beta Tubulin Antibody (clone TU-06), Clone: TU-06 |
|||
| APR13868G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A Monoclonal antibody against Human TUBB / Beta Tubulin (clone TU-06). The antibodies are raised in Mouse and are from clone TU-06. This antibody is applicable in WB and IHC-P, ICC |
|||
Total Protein - Murine Embryonic Stem Cell Line D3 |
|||
| CBA-305 | Cell Biolabs | 500 ?g | EUR 345 |
|
Description:
|
|||
Monoclonal HLA-E Antibody (clone MEM-E/06), Clone: MEM-E/06 |
|||
| AMM01844G | Leading Biology | 0.05mg | EUR 484 |
|
Description: A Monoclonal antibody against Human HLA-E (clone MEM-E/06). The antibodies are raised in Mouse and are from clone MEM-E/06. This antibody is applicable in IHC-P, IP, Flo |
|||
Influenza B Virus Florida 04/06 |
|||
| 7-07921 | CHI Scientific | 10µg | Ask for price |
Influenza B Virus Florida 04/06 |
|||
| 7-07922 | CHI Scientific | 50µg | Ask for price |
Influenza B Virus Florida 04/06 |
|||
| 7-07923 | CHI Scientific | 1mg | Ask for price |
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCA0227-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), APC conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCAP0227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCAP0227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC810227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC810227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF680R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC880227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC880227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF488A conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCB0227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCB0227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Biotin conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC550227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC550227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF555 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC470227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC470227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF647 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC940227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC940227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF594 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCP0227-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), PerCP conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC040227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC040227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF405S conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC050227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC050227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF405M conjugate, Concentration: 0.1mg/mL |
|||
Inactivated IBV Antigen (Florida 04/06) |
|||
| VAng-Lsx0363-inquire | Creative Biolabs | inquire | Ask for price |
|
Description: IBV (Florida 04/06), native virus from Embryonated egg. |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCR0227-250 | Biotium | 250uL | EUR 383 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), RPE conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNUB0227-100 | Biotium | 100uL | EUR 209 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Concentration: 0.2mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNUB0227-500 | Biotium | 500uL | EUR 458 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Concentration: 0.2mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC680227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC680227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF568 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC700227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC700227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF770 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC800227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC800227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF680 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC400227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC400227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF640R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC610227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC610227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF660R conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC430227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNC430227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), CF543 conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCH0227-100 | Biotium | 100uL | EUR 199 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNCH0227-500 | Biotium | 500uL | EUR 544 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
Milk Fat Globulin(MFG-06) Antibody |
|||
| BNUM0227-50 | Biotium | 50uL | EUR 395 |
|
Description: Primary antibody against Milk Fat Globulin(MFG-06), 1mg/mL |
|||
MDV Real-Time PCR Kit |
|||
| PD65-06 | Bionote | 96t | EUR 1553.6 |
|
Description: Please check the datasheet of MDV Real-Time PCR Kit before using the test. |
|||
16 Well Comb ,0.75mm Thick For Enduro 10cm Gel System |
|||
| LE1000C10-06 | GenDepot | Ea | EUR 128 |
16 Well Mc Comb ,1.5mm Thick For Enduro 15cm Gel System |
|||
| LE1000C15-06 | GenDepot | Ea | EUR 131 |
30 Well Comb ,1mm Thick For Enduro 20cm Gel System |
|||
| LE1000C20-06 | GenDepot | Ea | EUR 138 |
16 Well Comb , 1.5mm Thick For Enduro 7cm Gel System |
|||
| LE1000C7-06 | GenDepot | Ea | EUR 124 |
Gel Tray 20 X 20 Cm |
|||
| LE1000GT-06 | GenDepot | Ea | EUR 188 |
Lactate dehydrogenase (~550 U/mg), Porcine Muscle |
|||
| LDH-06 | Alpha Diagnostics | 20 KU | EUR 408 |
Recombinant Human IL-4 |
|||
| SJB02-06 | Amyotop | 30µg/vial | EUR 430 |
Lung Tissue Lysate (Tumor) |
|||
| 1703-06 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Lung tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Kidney Tissue Lysate (Tumor) |
|||
| 1707-06 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Kidney tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Breast Tissue Lysate (Normal) |
|||
| 1710-06 | ProSci | 0.1 mg | EUR 217.25 |
|
Description: Breast tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Breast Tissue Lysate (Tumor) |
|||
| 1714-06 | ProSci | 0.1 mg | EUR 280.25 |
|
Description: Breast tumor tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Colon Tissue Lysate (Normal) |
|||
| 1715-06 | ProSci | 0.1 mg | EUR 217.25 |
|
Description: Colon tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 5% β-mercaptoethanol. |
|||
Raji Lysate |
|||
| RF10001-06 | ProSci | 0.1 mg | EUR 191 |
|
Description: Raji lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The Raji lysate was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
| CBA-135 | Cell Biolabs | 96 assays | EUR 821 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric |
|||
| CBA-135-5 | Cell Biolabs | 5 x 96 assays | EUR 3356 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
| CBA-140 | Cell Biolabs | 96 assays | EUR 856 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Fluorometric |
|||
| CBA-140-5 | Cell Biolabs | 5 x 96 assays | EUR 3483 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
Influenza B (B / Florida / 04 / 06) Protein |
|||
| abx060629-1mg | Abbexa | 1 mg | EUR 1873 |
Influenza B Virus Florida 04 / 06 Protein |
|||
| 20-abx260512 | Abbexa |
|
|
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325 | Cell Biolabs | 96 assays | EUR 856 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
StemTAG Stem Cell Colony Formation Assay (Cell Recovery Compatible) |
|||
| CBA-325-5 | Cell Biolabs | 5 x 96 assays | EUR 3361 |
|
Description: Our StemTAG 96-Well Stem Cell Colony Formation Assay provides a high-throughput method to quantify ES cells in just 7-10 days, and no manual cell counting is required. Once colonies are formed, they may be analyzed in three different ways: 1. Lyse cells, then quantify in a fluorescence plate reader using dye included in the kit; 2. Lyse cells, then quantify alkaline phosphatase activity using reagents provided; or 3. Recover colonies from matrix for further culture or analysis. |
|||
CytoSelect Cell Transformation Assay (Cell Recovery Compatible), Colorimetric, Trial Size |
|||
| CBA-135-T | Cell Biolabs | 24 assays | EUR 432 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
CytoSelect 96-Well Cell Transformation Assay (Cell Recovery Compatible, Fluorometric), Trial Size |
|||
| CBA-140-T | Cell Biolabs | 24 assays | EUR 456 |
|
Description: CytoSelect 96-Well Cell Transformation Assays (Cell Recovery Compatible) provide a robust system for detecting transformed cells, screening cell transformation inhibitors, and determining in vitro drug sensitivity. A proprietary modified soft agar matrix allows you to either quantify cells using the included fluorescent dye, or recover the cells for further analysis. |
|||
Collagen-based Cell Contraction Assay |
|||
| CBA-201 | Cell Biolabs | 24 assays | EUR 485 |
|
Description: Cell Biolabs? Collagen-based Contraction Assay Kit provides a simple system to assess cell contractivity in vitro and screen cell contraction mediators. Each kit provides sufficient quantities to perform up to 24 assays in a 24-well plate. The kit can be also used in culturing cells in 3D collagen matrix. |
|||
CytoSelect MTT Cell Proliferation Assay |
|||
| CBA-252 | Cell Biolabs | 960 assays | EUR 409 |
|
Description: Cell Biolabs? CytoSelect MTT Cell Proliferation Assay provides a colorimetric format for measuring and monitoring cell proliferation. The kit contains sufficient reagents for the evaluation of 960 assays in 96-well plates or 192 assays in 24-well plates. Cells can be plated and then treated with compounds or agents that affect proliferation. Cells are then detected with the proliferation reagent, which is converted in live cells from the yellow tetrazole MTT to the purple formazan form by a cellular reductase (Figure 1). An increase in cell proliferation is accompanied by an increased signal, while a decrease in cell proliferation (and signal) can indicate the toxic effects of compounds or suboptimal culture conditions. The assay principles are basic and can be applied to most eukaryotic cell lines, including adherent and non-adherent cells and certain tissues. This cell proliferation reagent can be used to detect proliferation in bacteria, yeast, fungi, protozoa as well as cultured mammalian and piscine cells. |
|||
Rabbit Anti-CD274 monoclonal antibody, clone KK19-06 |
|||
| CAB-722RH | Creative Diagnostics | 100 ul | EUR 777 |